Acquisition of Distimp - Signing of the MOU
01 Juni 2021 - 05:45PM
Acquisition of Distimp - Signing of the MOU
Press
release
Ecully, 1
June
2021 – 5 :45
p.m.
Signature of a
Memorandum of Understandingfor the
acquisition of the
Distimp
start-up
Spineway, specialized
in innovative implants for the
treatment of severe disorders of the spinal column
(spine),
signed a Memorandum of Understanding for the
acquisition of
100% of the
capital – subject to
conditions precedent being met –
of Distimp, a European
start-up with which the Group
began exclusive negotiations last
March.1
Distimp, based in Nîmes, is specialized in the
design, manufacture and sale of implants and instruments for spinal
surgery. Its founder, Fabrice Paccagnella, lends the company his
solid experience gained from working in the spinal field designing
and developing implants and instruments for over 25 years, giving
him access to a large network of spinal surgeons, particularly in
France and in Europe. The company has several lines of innovative
products for spinal surgery that it sells directly in France and
via distributors internationally.
In line with the Group’s growth strategy, this
acquisition will allow Spineway to consolidate its product range
and strengthen its positions in Europe, particularly in France, by
making a wider variety of operating techniques with high added
value available and made for spinal surgeons.
This acquisition will be entirely financed in
cash2 and Mr. Fabrice Paccagnella will be integrated within the
Group as from the final signature of the agreement, which should
take place by the end of June.
Upcoming: 2021 half-year
revenue – 13 July 2021
SPINEWAY IS ELIGIBLE FOR THE PEA-PME
(EQUITY SAVINGS PLANS FOR SMES)Find out all about Spineway
at www.spineway.com
This press release has been prepared in both
English and French. In case of discrepancies, the French version
shall prevail.
Spineway
designs, manufactures and markets innovative implants and surgical
instruments for treating severe disorders of the spinal
column.Spineway has an international network of
over 50 independent distributors and 90% of its revenue comes from
exports.Spineway, which is eligible for investment
through FCPIs (French unit trusts specializing in innovation), has
received the OSEO Excellence award since 2011 and has won the
Deloitte Fast 50 award (2011). Rhône Alpes INPI Patent Innovation
award (2013) – INPI Talent award (2015). ISIN:
FR0011398874 - ALSPW
Contacts:
SPINEWAYShareholder-services lineAvailable Tuesday
through Thursday(10 a.m. – 12 p.m.)+33 (0)811 045 555 |
EligiblePEA / PMEALSPWEuronext Growth |
AELIUM Finance & CommunicationInvestor
relationsSolène Kennisspineway@aelium.fr |
1 See press release dated 18 March 20212 A sale price paid in
cash, and possibly additional payments due in 2022, 2023 and 2024
mainly based on average sales performance, gross margin and working
capital.
- SPW_CP ACCORD DISTIMP VDEF_GB
Spineway (EU:ALSPW)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Spineway (EU:ALSPW)
Historical Stock Chart
Von Mär 2023 bis Mär 2024